ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q1 2020 13F Holders as of 31 Mar 2020

Holder snapshot 7 signals
Share change
-1,069,107
Put/Call ratio
147%
SEC-reported price per share
$5.49
Number of holders
43
Value change
-$7,183,294
Number of buys
16
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
141,139,908

Security key

N71542109

Report period

Q1 2020

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F Lead comparable stake: 3.9% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 3.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 3.9%
RTW INVESTMENTS, LP 3.4%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3.2%
GOLDMAN SACHS GROUP INC 2.4%
JENNISON ASSOCIATES LLC 1.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.9%
$54,457,000
5,495,128 shares
31 Dec 2019
RTW INVESTMENTS, LP
13F
Company
13F
3.4%
$47,361,000
4,779,135 shares
31 Dec 2019
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
3.2%
$45,302,000
4,571,319 shares
31 Dec 2019
GOLDMAN SACHS GROUP INC
13F
Company
13F
2.4%
$33,200,000
3,350,192 shares
31 Dec 2019
JENNISON ASSOCIATES LLC
13F
Company
13F
1.9%
$26,070,000
2,630,626 shares
31 Dec 2019
Aquilo Capital Management, LLC
13F
Company
13F
1.4%
$19,053,000
1,922,570 shares
31 Dec 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
29,335,757
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders
43
Q1 2020 holders
43
Holder diff
0
Investor Q1 2020 Shares Q1 2020 Shares Share Diff Share Chg % Q1 2020 value Q1 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .